Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
ADPTAdaptive Biotechnologies(ADPT) ZACKS·2024-08-02 07:20

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of 0.26pershareversustheZacksConsensusEstimateofalossof0.26 per share versus the Zacks Consensus Estimate of a loss of 0.32. This compares to loss of 0.33pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof18.750.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.75%. A quarter ago, it was expected that this life-sciences research company would post a loss of 0.35 per share when it actually produced a loss of $0.33, delivering a surprise of 5.71%.Over the last four qua ...